Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Kyung Chan (KC) Park

BSc (Hons) DPhil AFHEA


British Heart Foundation Immediate Research Fellow in Cardio-Oncology

  • Honorary Research Fellow, Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, Guy's & St Thomas' NHS Foundation Trust

KC is a British Heart Foundation (BHF) Immediate Research Fellow in Cardio-Oncology, based in the laboratory of Prof. Claudia Monaco at the Kennedy Institute of Rheumatology, with co-mentorship from Dr Alexander Lyon at the Royal Brompton Hospital.

Cardio-oncology is an expanding multidisciplinary field focused on preventing and managing cardiovascular complications associated with cancer therapies. A key challenge is toxicity from novel targeted therapies, which contributes significantly to morbidity and mortality. KC’s research investigates the role of immune cells in immunotherapy-related cardiovascular toxicity, an emerging complication in cancer patients and survivors.

In addition to research, KC is an Associate Fellow of the Higher Education Academy and committed to promoting the development of early-career clinicians and scientists. At Oxford, he delivers lectures and tutorials in cardiovascular biology and supervises undergraduate research projects.

 

Background

KC studied Biomedical Sciences at King’s College London, completing his dissertation on cardiac troponin with Prof. Michael Marber (2015). He subsequently joined the laboratory of Prof. Michael Shattock at the Rayne Institute (BHF Centre of Research Excellence, King’s College London) on a Physiological Society Studentship.

He completed his PhD (DPhil) in Cardiovascular Science at the University of Oxford, supported by a BHF 4-Year Studentship, investigating the effects of dysregulated propionate metabolism on cardiac physiology (2021). His postdoctoral research expanded into epigenetics and metabolic-induced chromatin acylation with Prof. Thomas Milne at the MRC Weatherall Institute of Molecular Medicine.

KC’s research has been recognised by numerous awards including the Paul Dudley White International Scholar (American Heart Association, 2020), the Council of Basic Cardiovascular Science Young Investigator Award (European Society of Cardiology, 2022) and the Bernard and Joan Marshall Early Career Investigator Award (British Society for Cardiovascular Research, 2024).